Technology Commercialization Workshop Series
UCs Technology Commercialization Accelerator, led by Dorothy Air, PhD, will host a series of workshops at the College of Medicine to offer interested faculty a chance to learn more about entrepreneurialism, technology development and pathways to commercialization.
Each hour-and-a-half session will offer attendees the chance to talk with the Accelerators Entrepreneurs in Residence and/or faculty inventors about the process of turning ideas into commercial potential.
Lunch will be provided. RSVPs are required. RSVP to Tonya Mohn at tonya.mohn@uc.edu or 513-558-2485.
Session 1: Overview of Commercialization
Tuesday, June 3, 2014
11:30 a.m. to 1 p.m.
Medical Sciences Building, Room E-151
This session will share tips for getting started, myths about being an entrepreneur, success factors, managing roles (entrepreneur vs. faculty member) and available resources.
Session 2: Pathways to Development
Tuesday, July 1, 2014
11:30 a.m. to 1 p.m.
Medical Sciences Building, Room E-151
This session will help faculty learn to define opportunities and competitive edge and also offer information about establishing an intellectual property position and assessing market opportunity. Attendees will also hear about commercialization pathways, licensing vs. startups, and how to move things forward.
Session 3: Putting Your Idea on Path to Commercialization
Tuesday, August 5, 2014
11:30 a.m. to 1 p.m.
Medical Sciences Building, Room E-005h (Stanley Lucas Boardroom)
During this session, attendees will have the opportunity to share more about their own ideas and work to put a commercialization strategy around them. Attendees will also hear about what investors are seeking and learn how to apply to UCs Technology Commercialization Accelerator.
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.